ADENOSQUAMOUS CARCINOMA
Clinical trials for ADENOSQUAMOUS CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADENOSQUAMOUS CARCINOMA trials appear
Sign up with your email to follow new studies for ADENOSQUAMOUS CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill shows promise against tough cancers in early trial
Disease control OngoingThis Phase 2 trial tests an oral drug called ESK981 in people with advanced pancreatic cancer, neuroendocrine tumors, or neuroendocrine prostate cancer. The goal is to see if the drug can keep the cancer from growing for at least 4 months. Participants take the drug for 5 days, t…
Matched conditions: ADENOSQUAMOUS CARCINOMA
Phase: PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Freezing tumors to boost cancer treatment: early trial underway
Disease control OngoingThis early-phase trial tests a freezing treatment called cryotherapy, given before and during standard chemoradiation, for people with locally advanced esophageal cancer. The main goal is to find the safest number of cryotherapy sessions. Researchers will also check if the freezi…
Matched conditions: ADENOSQUAMOUS CARCINOMA
Phase: PHASE1 • Sponsor: Hunter Holmes Mcguire Veteran Affairs Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New drug combo aims to shrink pancreatic tumors before surgery
Disease control OngoingThis early-phase trial tests whether adding a targeted drug called ivosidenib to standard chemotherapy can help shrink pancreatic tumors before surgery. About 16 people with resectable pancreatic cancer that has a specific gene mutation (IDH1) will receive the drug combination fo…
Matched conditions: ADENOSQUAMOUS CARCINOMA
Phase: PHASE1 • Sponsor: Case Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 26, 2026 13:51 UTC